Delivery Order SPE2DB22D1017-SPE2DB25FH0AB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ML format, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 3, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This firm fixed price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,447.18 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a $2,447.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml format. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively competed. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml format, with a firm fixed price structure and an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and runs through December...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0ABDelivery Order
The Defense Logistics Agency awarded a $2,447.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product with an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serve as a critical supplier of pharmaceutical and medical commodities to federal healthcare systems. AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor supporting military and veteran healthcare needs through an extensive federal contract portfolio with DLA. The company holds a $999,999,999.00 prime IDC (SPE2DX) through December 2026 that enables global pharmaceutical support for military healthcare programs, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role as a key vendor within DLA's pharmaceutical supply chain, fulfilling specific medical product requirements for Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/18/25 |